Kevin Appelbaum or his successor(s) as Trustee of the Kevin Appelbaum Revocable Trust under Revocable Trust Declaration dated 5/16/2020 as amended 13D/13G Filings for Better Therapeutics, Inc. (<a rel="nofollow" class="qLink" href="#" OnClick="singleQuoteDialog('BTTX'); return false;">BTTX</a>)

Kevin Appelbaum or his successor(s) as Trustee of the Kevin Appelbaum Revocable Trust under Revocable Trust Declaration dated 5/16/2020 as amended 13D and 13G filings for Better Therapeutics, Inc.:

Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
Shares have been adjusted for stock splits.

Reported DateTime	Transaction Date	Type	Company Symbol	Filed By Symbol	Shares Owned % Owned	Shares Vs. Prev Report	View
2021-11-08 5:26 pm Purchase	2021-10-28	13D	Better Therapeutics, Inc. BTTX	Kevin Appelbaum or his successor(s) as Trustee of the Kevin Appelbaum Revocable Trust under Revocable Trust Declaration dated 5/16/2020 as amended	2,406,719 10.200%	2,406,719 (New Position)	Filing

Kevin Appelbaum or his successor(s) as Trustee of the Kevin Appelbaum Revocable Trust under Revocable Trust Declaration dated 5/16/2020 as amended 13D/13G Filings for Better Therapeutics, Inc. (BTTX)